Astra Zeneca CEO to Leave Following Weak Results - Presented by: The Aol. On Network

AstraZeneca PLC said Chief Executive David Brennan is leaving after the troubled drug maker missed its first-quarter earnings and sales forecasts and cut its full-year profit targets yet again. Dow Jones's Sten Stovall reports. Photo: Getty Images



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 12.65 0.47 ▲ 3.86%
TVIX $ 2.62 0.62 ▼ 19.14%
SIRI $ 3.83 0.07 ▲ 1.86%
BCS $ 7.3201 0.29 ▲ 4.13%
XIV $ 23.0215 1.56 ▲ 7.28%
FCX $ 10.7201 0.59 ▲ 5.83%
AAPL $ 93.1495 1.11 ▲ 1.21%
F $ 12.36 0.20 ▲ 1.64%

As of 6/28/2016, 03:00 PM